Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection

Hury Hellen Souza de Paula,Ana Cristina Garcia Ferreira,Diogo Gama Caetano,Edson Delatorre,Sylvia Lopes Maia Teixeira,Lara E. Coelho,Eduarda Grinsztejn João,Michelle Morata de Andrade,Sandra W. Cardoso,Beatriz Grinsztejn,Valdilea G. Veloso,Mariza G. Morgado,Monick Lindenmeyer Guimarães,Fernanda Heloise Côrtes

Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection

2018

Hury Hellen Souza de Paula
Ana Cristina Garcia Ferreira
Diogo Gama Caetano
Edson Delatorre
Sylvia Lopes Maia Teixeira
Lara E. Coelho
Eduarda Grinsztejn João
Michelle Morata de Andrade
Sandra W. Cardoso
Beatriz Grinsztejn
Valdilea G. Veloso
Mariza G. Morgado
Monick Lindenmeyer Guimarães
Fernanda Heloise Côrtes

Objectives To investigate the impact of early combined antiretroviral therapy (cART) on inflammation biomarkers and immune activation during acute and early chronic HIV-1 infection.

Keywords:

Antibody
Immunology
Interleukin 18
Immune system
Inflammation
Biomarker (medicine)
T cell
Cart
Biology
Systemic inflammation
CD38
Viral load
CD8

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations